Essential thrombocythemia during treatment of acute myeloid leukemia with JAK2 V617F mutation: A case report of a CARE-compliant article

RATIONALE: The JAK2 V617F mutation is frequently found in ET, while it is rare in de novo AML. ET has a low frequency of leukemic transformation. Both secondary AML (sAML) from ET and AML with JAK2 V617F mutation have poor prognoses. Because of the low incidence of JAK2 mutation in acute myeloid leu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Wenwen, Li, Danni, Zhuang, Chao, Wei, Pingping, Mou, Wenfeng, Zhang, Lei, Liang, Hui, Liu, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076173/
https://www.ncbi.nlm.nih.gov/pubmed/29979407
http://dx.doi.org/10.1097/MD.0000000000011331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076173/
https://www.ncbi.nlm.nih.gov/pubmed/29979407
http://dx.doi.org/10.1097/MD.0000000000011331

Ejemplares similares